We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
11 hedge funds and large institutions have $31.6M invested in Arcturus Therapeutics in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
167% more capital invested
Capital invested by funds: $11.8M → $31.6M (+$19.8M)
83% more funds holding
Funds holding: 6 → 11 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SC
Sophrosyne Capital
New York
|
+$1.47M |
| 2 |
JP Morgan Chase
New York
|
+$743K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$185K |
| 4 |
EEG
E.E. Geduld
|
+$127K |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$72.9K |
Top Sellers
| 1 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$1.26M |
| 2 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$159K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$3K |